Ping Yin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ping Yin has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
Lu Lu
Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China
2 shared publicationsBoon Chin Heng
School of Stomatology, Peking University, Beijing, China
1 shared publicationChen Yuanyuan
Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China
1 shared publicationCheng Xiang
Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China
1 shared publication- Guoqing Tong
Department of Reproductive Medicine, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi, China
1 shared publication He Junlan
Seventh People’s Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China
1 shared publication
Latest Publications
- Open Access
- 21 June 2025
- Published by Springer Nature in Journal of Ovarian Research
- Vol. 18 (1) , 1-11
Transcriptomic analysis of theca cells in a PCOS rat model: insights into follicular development
This study aimed to analyze differentially expressed genes in theca cells of polycystic ovary syndrome (PCOS) rats using transcriptomic sequencing. Bioinformatics analysis and PCR validation were performed to identify genes involved in follicular development regulation in PCOS. Twenty 6-week-old female SD rats with regular estrous cycles were divided into two groups (PCOS and control, n = 10 each). The PCOS model was induced with a 1.0 mg·kg⁻¹ Letrozole solution. Theca cells were collected for transcriptomic sequencing, and differentially expressed genes were analyzed. Functional annotations and pathway enrichment were determined using Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses. Gene interaction network and hub gene analyses were conducted, followed by RT-qPCR validation. PCOS rats exhibited increased body weight and irregular estrous cycles. A total of 1,114 differentially expressed genes were identified, including 516 upregulated and 598 downregulated genes. Fifty hub genes were selected for further analysis. GO and KEGG pathway enrichment analysis revealed significant involvement of the MAPK and PI3K-Akt signaling pathways. PCR validation confirmed that Cyp17a1, Cyp11a1, S6k1, mTOR, Akt, Kit, and Tek were significantly upregulated in the PCOS group (P < 0.05). Transcriptomic analysis identified key genes and pathways involved in follicular development dysregulation in PCOS rats, providing potential targets for further research.
- 21 June 2025
- Published by Springer Nature in Journal of Ovarian Research
- Vol. 18 (1) , 1-11
Open AccessTranscriptomic analysis of theca cells in a PCOS rat model: insights into follicular development
This study aimed to analyze differentially expressed genes in theca cells of polycystic ovary syndrome (PCOS) rats using transcriptomic sequencing. Bioinformatics analysis and PCR validation were performed to identify genes involved in follicular development regulation in PCOS. Twenty 6-week-old female SD rats with regular estrous cycles were divided into two groups (PCOS and control, n = 10 each). The PCOS model was induced with a 1.0 mg·kg⁻¹ Letrozole solution. Theca cells were collected for transcriptomic sequencing, and differentially expressed genes were analyzed. Functional annotations and pathway enrichment were determined using Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses. Gene interaction network and hub gene analyses were conducted, followed by RT-qPCR validation. PCOS rats exhibited increased body weight and irregular estrous cycles. A total of 1,114 differentially expressed genes were identified, including 516 upregulated and 598 downregulated genes. Fifty hub genes were selected for further analysis. GO and KEGG pathway enrichment analysis revealed significant involvement of the MAPK and PI3K-Akt signaling pathways. PCR validation confirmed that Cyp17a1, Cyp11a1, S6k1, mTOR, Akt, Kit, and Tek were significantly upregulated in the PCOS group (P < 0.05). Transcriptomic analysis identified key genes and pathways involved in follicular development dysregulation in PCOS rats, providing potential targets for further research.
- Open Access
- 8 November 2023
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 11, 1289063
Peptidomic analysis of follicular fluid in patients with polycystic ovarian syndrome
Objective: The aim of this study was to analyze and compare the differential expression of peptides within the follicular fluid of polycystic ovary syndrome (PCOS) patients versus normal women by using peptidomics techniques. The underlying mechanisms involved in PCOS pathogenesis will be explored, together with screening and identification of potential functional peptides via bioinformatics analysis.Materials and methods: A total of 12 patients who underwent in vitro fertilization and embryo transfer (IVF-ET) at the Reproductive Medicine Center of Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine from 1 September 2022 to 1 November 2022 were included in this study. The follicular fluid of PCOS patients (n = 6) and normal women (n = 6) were collected. The presence and concentration differences of various peptides were detected by the LC-MS/MS method. GO and KEGG analysis were performed on the precursor proteins of the differentially-expressed peptides, and protein network interaction analysis was carried out to identify functionally-relevant peptides among the various peptides.Results: A variety of peptides within the follicular fluid of PCOS versus normal patients were detected by peptidomics techniques. Altogether, 843 upregulated peptides and 236 downregulated peptides were detected (absolute fold change ≥2 and p < 0.05). Of these, 718 (718 = 488 + 230) peptides were only detected in the PCOS group, while 205 (205 = 174 + 31) were only detected in the control group. Gene Ontology enrichment and pathway analysis were performed to characterize peptides through their precursor proteins. We identified 18 peptides from 7 precursor proteins associated with PCOS, and 4 peptide sequences were located in the functional domains of their corresponding precursor proteins.Conclusion: In this study, differences in the follicular development of PCOS versus normal patients were revealed from the polypeptidomics of follicular development, which thus provided new insights for future studies on the pathological mechanisms of PCOS development.
- 8 November 2023
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 11, 1289063
Open AccessPeptidomic analysis of follicular fluid in patients with polycystic ovarian syndrome
Objective: The aim of this study was to analyze and compare the differential expression of peptides within the follicular fluid of polycystic ovary syndrome (PCOS) patients versus normal women by using peptidomics techniques. The underlying mechanisms involved in PCOS pathogenesis will be explored, together with screening and identification of potential functional peptides via bioinformatics analysis.Materials and methods: A total of 12 patients who underwent in vitro fertilization and embryo transfer (IVF-ET) at the Reproductive Medicine Center of Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine from 1 September 2022 to 1 November 2022 were included in this study. The follicular fluid of PCOS patients (n = 6) and normal women (n = 6) were collected. The presence and concentration differences of various peptides were detected by the LC-MS/MS method. GO and KEGG analysis were performed on the precursor proteins of the differentially-expressed peptides, and protein network interaction analysis was carried out to identify functionally-relevant peptides among the various peptides.Results: A variety of peptides within the follicular fluid of PCOS versus normal patients were detected by peptidomics techniques. Altogether, 843 upregulated peptides and 236 downregulated peptides were detected (absolute fold change ≥2 and p < 0.05). Of these, 718 (718 = 488 + 230) peptides were only detected in the PCOS group, while 205 (205 = 174 + 31) were only detected in the control group. Gene Ontology enrichment and pathway analysis were performed to characterize peptides through their precursor proteins. We identified 18 peptides from 7 precursor proteins associated with PCOS, and 4 peptide sequences were located in the functional domains of their corresponding precursor proteins.Conclusion: In this study, differences in the follicular development of PCOS versus normal patients were revealed from the polypeptidomics of follicular development, which thus provided new insights for future studies on the pathological mechanisms of PCOS development.